PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline.

Tew WP, Lacchetti C, Ellis A, Maxian K, Banerjee S, Bookman M, Jones MB, Lee JM, Lheureux S, Liu JF, Moore KN, Muller C, Rodriguez P, Walsh C, Westin SN, Kohn EC

Open source

DOI: 10.1200/jco.20.01924
Published: 2020 Oct 20
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.20.01924,
  title = {PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline.},
  author = {Tew WP and Lacchetti C and Ellis A and Maxian K and Banerjee S and Bookman M and Jones MB and Lee JM and Lheureux S and Liu JF and Moore KN and Muller C and Rodriguez P and Walsh C and Westin SN and Kohn EC},
  year = {2020},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco.20.01924},
  url = {https://doi.org/10.1200/jco.20.01924}
}

RIS

TY  - JOUR
TI  - PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline.
AU  - Tew WP
AU  - Lacchetti C
AU  - Ellis A
AU  - Maxian K
AU  - Banerjee S
AU  - Bookman M
AU  - Jones MB
AU  - Lee JM
AU  - Lheureux S
AU  - Liu JF
AU  - Moore KN
AU  - Muller C
AU  - Rodriguez P
AU  - Walsh C
AU  - Westin SN
AU  - Kohn EC
PY  - 2020
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco.20.01924
UR  - https://doi.org/10.1200/jco.20.01924
ER  -

APA

WP, T., C, L., A, E., K, M., S, B., M, B., MB, J., JM, L., S, L., JF, L., KN, M., C, M., P, R., C, W., SN, W., & EC, K. (2020). PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.20.01924

Source records

pubmed · retrieved 2026-09-26T06:48:54.752Z